Clinical Journal of Gastroenterology · Published 2026-06-14 · DOI 10.1007/s12328-026-02373-6
Takayuki Tanaka, Yorihisa Sumida, Takahiro Ikeda, Akiko Fukuda, Makoto Hisanaga, Kohki Wakata, Masato Araki, Hiroko Hayashi, Kosuke Nakamura, Masaaki Hidaka
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Tanaka, T., Sumida, Y., Ikeda, T., et al. (2026). Paradoxical hyperprogressive disease in MSI-high intrahepatic cholangiocarcinoma treated with pembrolizumab. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-026-02373-6